Clover Health Investments Corp
NASDAQ:CLOV
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
US |
Clover Health Investments Corp
NASDAQ:CLOV
|
438.4m USD | 0.2 | ||
US |
UnitedHealth Group Inc
NYSE:UNH
|
483.7B USD | 1.3 | ||
US |
Elevance Health Inc
NYSE:ELV
|
127.2B USD | 0.7 | ||
US |
Anthem Inc
NYSE:ANTM
|
116.4B USD | 0.8 | ||
US |
Humana Inc
NYSE:HUM
|
42.9B USD | 0.4 | ||
US |
Centene Corp
NYSE:CNC
|
41.8B USD | 0.3 | ||
US |
Molina Healthcare Inc
NYSE:MOH
|
20.4B USD | 0.6 | ||
US |
Healthequity Inc
NASDAQ:HQY
|
6.8B USD | 6.8 | ||
BR |
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
33.8B BRL | 1.2 | ||
BR |
Notre Dame Intermedica Participacoes SA
OTC:NTEDY
|
6.4B USD | 3.2 | ||
US |
Progyny Inc
NASDAQ:PGNY
|
2.7B USD | 2.5 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.